Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer

Journal of Gastrointestinal Oncology

Gregory Wilding¹  Boris Kuvshinoff¹  Graham Warren³  Leayn Flaherty³  Gary Y. Yang²  Wen-Wee Ma¹  Kilian Salerno May³  Rameela Chandrasekhar¹  Nadia K. Malik³  John Gibbs¹  Renuka Iyer¹ 

[1] Department of Radiation Medicine, Loma Linda University Medical Center, Loma Linda, California, USADepartment of Radiation Medicine, Loma Linda University Medical Center, Loma Linda, California, USADepartment of Radiation Medicine, Loma Linda University Medical Center, Loma Linda, California, USA;Department of Radiation Medicine, 3Department of Biostatistics, 4Department of Medical Oncology and 5Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA Department of Radiation Medicine, 3Department of Biostatistics, 4Department of Medical Oncology and 5Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA Department of Radiation Medicine, 3Department of Biostatistics, 4Department of Medical Oncology and 5Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA

关键词: CA19-9;    pancreatic cancer;    chemoradiotherapy (CRT);   

DOI  :  10.3978/j.issn.2078-6891.2013.045

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown